Search clinical trials for: Anti-PD1/PDL1

Total 97600 results

Chinese Anti-Cancer Association

Unknown

The Registration Program of BRCA1/2 Gene (RCA)

Breast Cancer

China
Zhejiang Cancer Hospital

Not yet recruiting

HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis

Gastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and Surgery

China
Chulalongkorn University

Terminated

Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment

Anti-r-HuEpo Associated PRCA Subjects

Thailand
University Hospital, Montpellier

Completed

Texture Features and PDL1 in CT-PET 18 FDG

Non Small Cell Lung Cancer

France
Onconic Therapeutics Inc.

Completed

Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian

Anti-Ulcer Agents

Korea, Republic of
Annelies Verbon
University Hospital, Geneva; Erasmus Medical Center; Uppsala University Hospital and other collaborators

Unknown

A Digital Antimicrobial Stewardship Smartphone Application to Combat AMR: the AB-assistant (AB-assistant)

Mobile Applications | Quality Improvement | Anti-Infective Agents | Antimicrobial Stewardship

Canada, Netherlands, Sweden, Switzerland
Eskisehir Osmangazi University
TC Erciyes University

Completed

The Effects of Antibiotic Combinations on Stem Cells

Anti-Bacterial Agents | Stem Cells

Turkey
University of the West of England
Unilever R&D

Recruiting

The Evaluation of Two Positive Body Image Micro-interventions for Children Aged 4-6 Years

Body Image | Anti Fat Bias

United Kingdom
Sohag University

Not yet recruiting

PDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact

PDL1- Colorectal Carcinoma
National Institute of Allergy and Infectious Diseases...

Recruiting

Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products

Physiological Effects of Drugs | Anti-Infective Agents | Vaccines | Immunologic Factors | Antiviral Agents

United States
Sandoz

Completed

A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and ANTI-ANGIN® FORMULA, Lozenges, in Treatment of Patients With a Sore Throat

Sore Throat

Russian Federation
Keimyung University Dongsan Medical Center

Completed

Effect of Oral Phloroglucin (Flospan®) as Premedication of Non-sedative Diagnostic Esophagogastroduodenoscopy

Anti-spasmodics | Gastric Peristalsis | Non-sedative Endoscopy

Korea, Republic of
Ascopharm Groupe Novasco
Groupe Hospitalier Pitie-Salpetriere; Medco Health Solutions, Inc.

Completed

Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction. (DOSAPI)

Anti Platelet Effects

France
SOLTI Breast Cancer Research Group
Novartis

Recruiting

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors (ACROPOLI)

Melanoma | Sarcoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Uterine Carcinosarcoma | Mesothelioma | Cholangiocarcinoma | Lung Adenocarcinoma | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | HER2-positive Breast Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal... and other conditions

Spain
Chang Gung Memorial Hospital

Completed

Long-term Outcomes of Living Donor Liver Transplantations With Anti-HBc (+) Grafts in Pediatric Patients

Living Donor Liver Transplantations With Anti-HBc (+) Grafts
Chulalongkorn University

Completed

Topical Bevacizumab for Preventing Recurrent Pterygium

Pterygium | Bevacizumab | VEGF | Anti-VEGF

Thailand
Instituto Nacional de Cancerologia de Mexico

Completed

MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients

Carcinoma, Non-Small-Cell Lung

Mexico
Universitaire Ziekenhuizen KU Leuven

Completed

Acid Suppressive Therapy - Review of Appropriateness (ASTRA)

Appropriate Startup of Acid Suppressive Therapy

Belgium
Mahidol University

Unknown

Olanzapine Versus Aprepitant Based Antiemetic Regimen for High Emetic Chemotherapy

Antiemetic for Highly Emetogenic Chemotherapy

Thailand
CHU de Reims

Active, not recruiting

Autoantibodies Prevalence During Checkpoint Inhibitor Treatment

Autoimmune Adverse Effects of Anti-neoplasic Drug

France
Keyvan Koushan

Completed

Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser (DAM)

Diabetic Macular Edema

Canada
Checkpoint Therapeutics, Inc.

Terminated

Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab (CK-301) in First Line Metastatic Non-squamous Non-Small Cell Lung Cancer (CONTERNO)

Metastatic Non-squamous Non Small Cell Lung Cancer

Peru, Russian Federation, South Africa, New Zealand, Georgia, Thailand, Brazil, Malaysia
The First Affiliated Hospital of Dalian Medical...

Completed

Ticagrelor in Elderly Patients Undergoing Percutaneous Coronary Intervention

Percutaneous Coronary Intervention | Aged | Platelet Aggregation Inhibitors | Dual Anti-Platelet Therapy

China
Centre National d'Etudes Spatiales
European Space Agency; National Space Development Agency, Japan

Completed

Toulouse Male Long Term Bed Rest 2001-2002

Simulation of Weightlessness by Anti-Orthostatic Long Term Bed Rest

France
TILT Biotherapeutics Ltd.
Merck Sharp & Dohme LLC

Recruiting

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA)

Platinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditions

United States, Finland
Beijing Tsinghua Chang Gung Hospital

Recruiting

Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Hepatocellular Carcinoma

China
Rakuten Medical, Inc.

Active, not recruiting

An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors

Recurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head-and-neck Squamous-cell Carcinoma | Metastatic Cutaneous Squamous Cell Carcinoma | Locally Advanced Cutaneous Squamous Cell Carcinoma

United States
Royal Marsden NHS Foundation Trust

Unknown

A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR) (ADAPTeR)

Renal Cell Carcinoma

United Kingdom
Polyneuron Pharmaceuticals AG

Terminated

First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy

Anti-MAG Neuropathy

Spain, France, Netherlands, Switzerland, United Kingdom
Hospices Civils de Lyon

Unknown

LGI1-antibody Patients Follow-up (evoLGI1)

Anti-LGI1 Encephalitis

France
New York University
National Institute of Mental Health (NIMH); Beth Israel Medical Center; St. Luke...

Completed

Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline (Heart to Heart)

HIV | Antiretroviral Therapy

United States
Pharmanex
Aspen Clinical Research

Completed

Effects of a Proprietary Blend of Herbal Extract Supplement on Cellular Detoxification, Inflammation, and Cumulative Cognitive Index as Well as Gene Expression in Middle-Aged Adult Women (Pharmanex)

Anti Aging

United States
Regeneron Pharmaceuticals

Not yet recruiting

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

Melanoma
Sun Yat-sen University

Recruiting

An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1（Programmed Cell Death Protein 1） Antibody in Recurrent/ Advanced Stage Endometrial Cancer Patients

Recurrent/ Advanced Stage Endometrial Cancer Patients

China
Bristol-Myers Squibb

Completed

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC (CheckMate057)

Non-Squamous Cell Non-small Cell Lung Cancer

United States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

Extravasations of Anthracycline Anti-cancer Agents

Japan
Merck Sharp & Dohme LLC

Recruiting

Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

Advanced Solid Tumors | Metastatic Solid Tumors

Canada, Switzerland, United States
Merck Sharp & Dohme LLC

Completed

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study

Esophageal Carcinoma | Esophagogastric Junction Carcinoma

China
Merck Sharp & Dohme LLC

Completed

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)

Esophageal Carcinoma | Esophagogastric Junction Carcinoma
Mårten Segelmark
Hansa Biopharma AB

Completed

Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease (GOOD-IDES-01)

Anti-Glomerular Basement Membrane Antibody Disease

Austria, Czechia, Denmark, France, Sweden
Zhejiang Cancer Hospital

Active, not recruiting

Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study. (NSCLC)

Non-small Cell Lung Cancer | PDL1 Gene Mutation

China
Merck Sharp & Dohme LLC

Completed

First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)

Esophageal Neoplasms

Taiwan, China, United States, Argentina, Australia, Brazil, Canada, Chile, Colombia, Costa Rica, Denmark, France, Germany, Guatemala, Hong Kong, Japan, Korea, Republic of, Malaysia, Peru, Romania, Russian Federation, South Africa, S... and more
Merck Sharp & Dohme LLC

Completed

Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052)

Urothelial Cancer
Tianjin Medical University Cancer Institute and...

Recruiting

PD1 and PARP for Maintenance Therapy in NSLLC

Lung Cancer

China
Shanghai Zhongshan Hospital
RenJi Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine and other collaborators

Recruiting

Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Intrahepatic Cholangiocarcinoma | Lenvatinib | PD1 Antibody | Gemox Chemotherapy

China
Beckman Coulter, Inc.

Not yet recruiting

Access Anti-HAV and Access Anti-HAV IgM Assays EU Clinical Trial Protocol (HAV-EU-11-23)

HAV

France
Chandrikha Chandrasekharan
AstraZeneca; Biocompatibles UK Ltd

Suspended

Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer (iRE-C)

Metastatic Colorectal Cancer | Colorectal Neoplasms | Rectal Cancer | Colon Cancer | Colorectal Cancer Metastatic | Liver Metastases | Colo-rectal Cancer | Colorectal Carcinoma | Colorectal Adenocarcinoma | Liver Metastasis Colon Cancer

United States
Yan Li

Active, not recruiting

Antihypertensive Treatment in Masked Hypertension for Target Organ Protection (ANTI-MASK)

Masked Hypertension

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy

Locally Advanced Non-Small Cell Lung Cancer

China
University Hospital, Lille

Completed

Antagonism Research Between Antiemetics Agents and Acetaminophen in Thyroidectomy's Post-operative Analgesia. (ANPATHY)

Interaction Between Antiemetic Drugs and Paracetamol

France

Search clinical trials for: Anti-PD1/PDL1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations